Compare iShares MSCI Australia ETF (EWA) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Australia ETF vs UnitedHealth Group Inc — how do they compare? iShares MSCI Australia ETF trades at $28.62 (market cap $1.17B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 284.6× iShares MSCI Australia ETF's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while iShares MSCI Australia ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Australia ETF for 61 Days and UnitedHealth Group Inc for 97 Days on average.
| EWA | UNH | |
|---|---|---|
Market Cap | $1.17B | $332.96B |
Volume | 2,121,231 | 7,273,749 |
Sector | Broad Market / Factor | Health |
52-Week High | $30.43 | $436.35 |
52-Week Low | $24.95 | $259.02 |
Typical Hold Time | 61 Days | 97 Days |
Enterprise Value | — | $374.82B |
Dividend Yield | — | 2.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The iShares MSCI Australia ETF (EWA) trades at $28.23, showing no change over the past 24 hours. Technical indicators are predominantly bearish, with moving averages signaling a sell and oscillators neutral. Recent news highlights institutional selling by Squarepoint Ops LLC and broader Australian market pressures from inflation concerns, though some analysts see upside potential tied to commodity exposure.
The outlook is mixed; EWA offers exposure to Australia's commodity-driven economy with potential for gains if raw material prices rise, but faces headwinds from inflation and monetary policy tightening. Key risks include economic sensitivity to global demand and market volatility. Analyst sentiment is divided, with some targeting over 20% upside.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Australia ETF
EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.
Read more on EWA →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
